本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Jasper Therapeutics

2.10
-0.1800-7.89%
盤後2.100.0007+0.03%18:34 EST
成交量:32.42萬
成交額:68.91萬
市值:5,864.05萬
市盈率:-0.35
高:2.26
開:2.26
低:2.05
收:2.28
52周最高:26.05
52周最低:2.05
股本:2,792.40萬
流通股本:2,281.03萬
量比:0.89
換手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-6.0237
每股收益(LYR):-4.8865
淨資產收益率:-146.87%
總資產收益率:-73.30%
市淨率:2.50
市盈率(LYR):-0.43

資料載入中...

2021/10/29

重要事件披露

8-K - Current report
2021/10/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/18

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/10/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/29

重要事件披露

8-K - Current report
2021/09/29

重要事件披露

8-K/A [Amend] - Current report
2021/09/27

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/09/23

重要事件披露

8-K - Current report
2021/09/20

重要事件披露

8-K - Current report
2021/09/20

企業合併公告

425 - Prospectuses and communications, business combinations
2021/09/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/09

重要事件披露

8-K - Current report
2021/09/09

企業合併公告

425 - Prospectuses and communications, business combinations
2021/09/08

企業合併公告

425 - Prospectuses and communications, business combinations